DUBLIN--(BUSINESS WIRE)--The "US Hospital Infectious Disease Market Forecasts for 100 Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review" report has been added to ResearchAndMarkets.com's offering.
This report presents a comprehensive analysis of the US hospital infectious disease testing market, including:
- Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.
- Volume and sales forecasts for 80 infectious disease tests performed in US hospital laboratories.
- Instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers by test.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
For more information about this report visit https://www.researchandmarkets.com/r/noyo9s
